CD8A and neoplasm: This was insufficient to meet predefined threshold criteria for efficacy, although the limited number of paired tumor biopsies examined did demonstrate the expected bioactivity, including a reduction in CSF1-dependent CD16-expressing monocytes, and increased CD4+ and CD8+ T cell numbers [195].